Cargando…
A comparative pharmaco-metabolomic study of glutaminase inhibitors in glioma stem-like cells confirms biological effectiveness but reveals differences in target-specificity
Cancer cells upregulate anabolic processes to maintain high rates of cellular turnover. Limiting the supply of macromolecular precursors by targeting enzymes involved in biosynthesis is a promising strategy in cancer therapy. Several tumors excessively metabolize glutamine to generate precursors for...
Autores principales: | Koch, Katharina, Hartmann, Rudolf, Tsiampali, Julia, Uhlmann, Constanze, Nickel, Ann-Christin, He, Xiaoling, Kamp, Marcel A., Sabel, Michael, Barker, Roger A., Steiger, Hans-Jakob, Hänggi, Daniel, Willbold, Dieter, Maciaczyk, Jaroslaw, Kahlert, Ulf D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7162917/ https://www.ncbi.nlm.nih.gov/pubmed/32337072 http://dx.doi.org/10.1038/s41420-020-0258-3 |
Ejemplares similares
-
Overexpression of Cystine/Glutamate Antiporter xCT Correlates with Nutrient Flexibility and ZEB1 Expression in Highly Clonogenic Glioblastoma Stem-like Cells (GSCs)
por: Koch, Katharina, et al.
Publicado: (2021) -
Enzymatic Activity of CD73 Modulates Invasion of Gliomas via Epithelial–Mesenchymal Transition-Like Reprogramming
por: Tsiampali, Julia, et al.
Publicado: (2020) -
Reciprocal regulation of the cholinic phenotype and epithelial-mesenchymal transition in glioblastoma cells
por: Koch, Katharina, et al.
Publicado: (2016) -
A computational guided, functional validation of a novel therapeutic antibody proposes Notch signaling as a clinical relevant and druggable target in glioma
por: Herrera-Rios, Dayana, et al.
Publicado: (2020) -
Testing the Stability of Drug Resistance on Cryopreserved, Gene-Engineered Human Induced Pluripotent Stem Cells
por: Khan, Dilaware, et al.
Publicado: (2021)